JP2021510528A5 - - Google Patents
Info
- Publication number
- JP2021510528A5 JP2021510528A5 JP2020539801A JP2020539801A JP2021510528A5 JP 2021510528 A5 JP2021510528 A5 JP 2021510528A5 JP 2020539801 A JP2020539801 A JP 2020539801A JP 2020539801 A JP2020539801 A JP 2020539801A JP 2021510528 A5 JP2021510528 A5 JP 2021510528A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- pharmaceutical composition
- sequence
- composition according
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18152133 | 2018-01-17 | ||
| EP18152133.7 | 2018-01-17 | ||
| PCT/EP2019/051128 WO2019141765A1 (en) | 2018-01-17 | 2019-01-17 | A modified raav capsid protein for gene therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021510528A JP2021510528A (ja) | 2021-04-30 |
| JP2021510528A5 true JP2021510528A5 (cg-RX-API-DMAC7.html) | 2022-02-24 |
| JP7389040B2 JP7389040B2 (ja) | 2023-11-29 |
Family
ID=61022137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539801A Active JP7389040B2 (ja) | 2018-01-17 | 2019-01-17 | 遺伝子治療のための修飾rAAVキャプシドタンパク質 |
Country Status (27)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL314171A (en) | 2015-09-28 | 2024-09-01 | Univ Florida | Methods and compositions for antibody-evading virus vectors |
| CN111511375A (zh) * | 2017-06-30 | 2020-08-07 | 因提玛生物科学公司 | 用于基因治疗的腺相关病毒载体 |
| JP7389040B2 (ja) | 2018-01-17 | 2023-11-29 | メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド | 遺伝子治療のための修飾rAAVキャプシドタンパク質 |
| CA3095179A1 (en) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Antibody-evading virus vectors |
| BR112020020266A2 (pt) | 2018-04-03 | 2021-01-19 | Stridebio, Inc. | Vetores de vírus com evasão de anticorpos |
| MX2020010465A (es) | 2018-04-03 | 2021-01-08 | Vectores de virus para direccionamiento a tejidos oftalmicos. | |
| CN110437317B (zh) * | 2019-01-30 | 2023-05-02 | 上海科技大学 | 具有变异衣壳蛋白的腺相关病毒及其用途 |
| CN113727992A (zh) | 2019-03-21 | 2021-11-30 | 斯特里迪比奥公司 | 重组腺相关病毒载体 |
| SMT202400486T1 (it) * | 2019-07-15 | 2025-01-14 | Meiragtx Uk Ii Ltd | Proteine di capside avv modificate per il trattamento della malattia artritica |
| CN114787180A (zh) | 2019-10-17 | 2022-07-22 | 斯特里迪比奥公司 | 用于治疗c型尼曼-匹克病的腺相关病毒载体 |
| MX2022004353A (es) | 2019-10-17 | 2022-07-19 | Casete de transferencia de aav. | |
| CN110950934B (zh) * | 2019-12-31 | 2022-11-04 | 复旦大学 | 一种腺相关病毒衣壳蛋白、载体及其构建方法与应用 |
| TW202142554A (zh) * | 2020-02-25 | 2021-11-16 | 澳洲兒童醫學研究所 | 腺相關病毒蛋白殼多肽及載體 |
| JP2023542614A (ja) | 2020-08-19 | 2023-10-11 | サレプタ セラピューティクス, インコーポレイテッド | レット症候群の治療のためのアデノ随伴ウイルスベクター |
| GB202110014D0 (en) * | 2021-07-12 | 2021-08-25 | Cytiva Bioprocess R & D Ab | A method for separating adeno-associated virus capsids, compositions obtained by said method and uses thereof |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス,インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| EP4694906A1 (en) | 2023-04-13 | 2026-02-18 | MeiraGTx Gene Regulation Limited | Inflammation-inducible promoters |
| CN119320802A (zh) * | 2023-07-17 | 2025-01-17 | 苏州吉恒基因科技有限公司 | 单链单极DNA重组腺相关病毒的cis包装元件、spAAV载体和应用 |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| EP1572893B1 (en) | 2001-11-09 | 2009-01-07 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | Production of adeno-associated virus in insect cells |
| AU2010201278B2 (en) | 2003-09-01 | 2012-11-15 | Academisch Medisch Centrum | AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| US8529885B2 (en) | 2003-09-01 | 2013-09-10 | Academisch Medisch Centrum | AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| WO2005021768A1 (en) * | 2003-09-01 | 2005-03-10 | Academisch Medisch Centrum | Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| PT3272872T (pt) | 2005-10-20 | 2020-06-26 | Uniqure Ip Bv | Vetores aav melhorados produzidos em células de insetos |
| US7588772B2 (en) * | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| WO2007148971A2 (en) | 2006-06-21 | 2007-12-27 | Amsterdam Molecular Therapeutics B.V. | Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells |
| ES2385679T3 (es) | 2006-08-24 | 2012-07-30 | Virovek, Inc. | Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos |
| EP2012122A1 (en) | 2007-07-06 | 2009-01-07 | Medigene AG | Mutated parvovirus structural proteins as vaccines |
| HUE029744T2 (en) | 2007-07-26 | 2017-04-28 | Uniqure Ip Bv | Baculoviral vectors comprising repeated coding sequences with differential codon biases |
| AU2009215987B2 (en) | 2008-02-19 | 2015-01-22 | Uniqure Ip B.V. | Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| US20110171262A1 (en) | 2008-06-17 | 2011-07-14 | Andrew Christian Bakker | Parvoviral capsid with incorporated gly-ala repeat region |
| EP2545165B1 (en) | 2010-03-11 | 2020-07-29 | uniQure IP B.V. | Mutated rep encoding sequences for use in aav production |
| JP6198278B2 (ja) | 2011-09-08 | 2017-09-20 | ユニキュアー アイピー ビー.ブイ. | Aav調製物からの混入ウイルスの除去 |
| WO2013174760A1 (en) * | 2012-05-25 | 2013-11-28 | Deutsches Krebsforschungszentrum | Optimized aav-vectors for high transduction rates in dendritic cells |
| KR102298579B1 (ko) * | 2013-05-21 | 2021-09-07 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 |
| DE102014207498A1 (de) * | 2014-04-17 | 2015-10-22 | Universitätsklinikum Hamburg-Eppendorf | Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark |
| CN104107438A (zh) | 2014-05-29 | 2014-10-22 | 中国人民解放军军事医学科学院基础医学研究所 | Spry2在制备预防和治疗类风湿性关节炎药物中的应用 |
| CN107002096A (zh) * | 2014-10-06 | 2017-08-01 | 阿罗根有限公司 | 基于aav的基因疗法 |
| JP6754361B2 (ja) | 2014-12-16 | 2020-09-09 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ | 若年型バッテン病のための遺伝子療法 |
| MX381665B (es) | 2016-01-13 | 2025-03-13 | Genzyme Corp Star | Vectores aav recombinantes que expresan genes osteoprotectores, que incluyen has2 y lubricina, de utilidad en el tratamiento de la osteoartritis y afecciones articulares relacionadas en mamiferos. |
| ES2982489T3 (es) | 2016-08-19 | 2024-10-16 | Univ Florida | Composiciones para el tratamiento de afecciones que utilizan virus adeno-asociados recombinantes autocomplementarios |
| US11958886B2 (en) | 2016-12-07 | 2024-04-16 | University Of Florida Research Foundation, Incorporated | IL-1RA cDNAs |
| EP4219806A3 (en) | 2017-04-11 | 2023-09-27 | Ruprecht-Karls-Universität Heidelberg | Adeno-associated virus library |
| UY37863A (es) | 2017-08-31 | 2019-03-29 | Benitec Biopharma Ltd | Virus adenoasociado (aav) con dominio de fosfolipasa modificado |
| JP7389040B2 (ja) | 2018-01-17 | 2023-11-29 | メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド | 遺伝子治療のための修飾rAAVキャプシドタンパク質 |
| SMT202400486T1 (it) * | 2019-07-15 | 2025-01-14 | Meiragtx Uk Ii Ltd | Proteine di capside avv modificate per il trattamento della malattia artritica |
-
2019
- 2019-01-17 JP JP2020539801A patent/JP7389040B2/ja active Active
- 2019-01-17 HR HRP20231126TT patent/HRP20231126T1/hr unknown
- 2019-01-17 PL PL19701080.4T patent/PL3740222T3/pl unknown
- 2019-01-17 HU HUE19701080A patent/HUE062774T2/hu unknown
- 2019-01-17 EA EA202091712A patent/EA202091712A1/ru unknown
- 2019-01-17 ES ES19701080T patent/ES2957622T3/es active Active
- 2019-01-17 DK DK19701080.4T patent/DK3740222T5/da active
- 2019-01-17 WO PCT/EP2019/051128 patent/WO2019141765A1/en not_active Ceased
- 2019-01-17 LT LTEPPCT/EP2019/051128T patent/LT3740222T/lt unknown
- 2019-01-17 AU AU2019209595A patent/AU2019209595B2/en not_active Ceased
- 2019-01-17 SI SI201930613T patent/SI3740222T1/sl unknown
- 2019-01-17 SG SG11202006056RA patent/SG11202006056RA/en unknown
- 2019-01-17 SM SM20230284T patent/SMT202300284T1/it unknown
- 2019-01-17 FI FIEP19701080.4T patent/FI3740222T3/fi active
- 2019-01-17 RS RS20230730A patent/RS64499B1/sr unknown
- 2019-01-17 EP EP19701080.4A patent/EP3740222B1/en active Active
- 2019-01-17 CN CN201980020100.1A patent/CN112004544B/zh active Active
- 2019-01-17 KR KR1020207023174A patent/KR102919991B1/ko active Active
- 2019-01-17 US US16/962,748 patent/US12480138B2/en active Active
- 2019-01-17 BR BR112020014625-0A patent/BR112020014625A2/pt not_active Application Discontinuation
- 2019-01-17 MX MX2020006764A patent/MX2020006764A/es unknown
- 2019-01-17 IL IL275838A patent/IL275838B2/en unknown
- 2019-01-17 PT PT197010804T patent/PT3740222T/pt unknown
- 2019-01-17 CA CA3087910A patent/CA3087910C/en active Active
- 2019-01-17 MY MYPI2020003653A patent/MY202252A/en unknown
-
2020
- 2020-07-17 PH PH12020551096A patent/PH12020551096A1/en unknown
- 2020-08-12 ZA ZA2020/04980A patent/ZA202004980B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275838B2 (en) | A modified raav capsid protein for gene therapy | |
| JP2022541520A5 (cg-RX-API-DMAC7.html) | ||
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| JP2023544683A5 (cg-RX-API-DMAC7.html) | ||
| JP2026027271A5 (cg-RX-API-DMAC7.html) | ||
| JP2023126919A5 (cg-RX-API-DMAC7.html) | ||
| Danos et al. | Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. | |
| RU2233333C2 (ru) | Вирусные векторы и их применение в генной терапии | |
| FI3313991T3 (fi) | Muunnettu tekijä IX sekä koostumukset, menetelmät ja käytöt geeninsiirtoa varten soluihin, elimiin ja kudoksiin | |
| Momma et al. | Glycinin A5A4B3 mRNA: cDNA cloning and nucleotide sequencing of a splitting storage protein subunit of soybean | |
| EP0429483B1 (en) | Potyvirus coat protein genes and plants transformed therewith | |
| JP2022530544A5 (cg-RX-API-DMAC7.html) | ||
| RU2020113681A (ru) | Капсиды вариантов аденоассоциированных вирусов и методы их применения | |
| CN114057840B (zh) | 包含变异的aav9衣壳蛋白的重组腺相关病毒颗粒 | |
| JP2014239686A5 (cg-RX-API-DMAC7.html) | ||
| JP2022531861A5 (cg-RX-API-DMAC7.html) | ||
| Jeong et al. | Characterization of the DNA nucleotide sequences in the genome of red sea bream iridoviruses isolated in Korea | |
| FI3999119T3 (fi) | Muokattuja aav-kapsidiproteiineja niveltulehdussairauden hoitoon | |
| CN113039275B (zh) | 用于在植物中表达猪圆环病毒样颗粒的重组载体以及使用其的疫苗组合物 | |
| FI4536686T3 (fi) | Lihaksen parannetun transduktiotehokkuuden omaava peptidimodifioitu aav-kapsidi | |
| JP2023549357A5 (cg-RX-API-DMAC7.html) | ||
| JP2024503091A5 (cg-RX-API-DMAC7.html) | ||
| JP2023550581A5 (cg-RX-API-DMAC7.html) | ||
| CN108530528A (zh) | 一种重组人tsg-6蛋白及其制备方法和在急性炎症性疾病中的应用 | |
| Tousch et al. | Replication of cucumber mosaic virus satellite RNA from negative-sense transcripts produced either in vitro or in transgenic plants |